Marta Casquero-Veiga

Dr. Marta Casquero-Veiga

orcid
Postdoctoral associate

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MCMarta Casquero-Veiga
Marta Casquero-Veiga
DGDavid García-García
David García-García
KMKarina MacDowell
Karina MacDowell
LPLaura Pérez-Caballero
Laura Pérez-Caballero
STSonia Torres-Sánchez
Sonia Torres-Sánchez
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro

1 May 2021 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MCMarta Casquero-Veiga
Marta Casquero-Veiga
DRDiego Romero-Miguel
Diego Romero-Miguel
KMKarina S. MacDowell
Karina S. MacDowell
STSonia Torres-Sanchez
Sonia Torres-Sanchez
JGJose Antonio Garcia-Partida
Jose Antonio Garcia-Partida
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro

24 June 2021 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
DRDiego Romero-Miguel
Diego Romero-Miguel
MCMarta Casquero-Veiga
Marta Casquero-Veiga
KMKarina S MacDowell
Karina S MacDowell
STSonia Torres-Sanchez
Sonia Torres-Sanchez
JGJosé Antonio Garcia-Partida
José Antonio Garcia-Partida
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro
Background: Minocycline (MIN) is a tetracycline with antioxidant, anti-inflammatory, and neuroprotective properties. Given the likely involvement of inflammation and oxidative stress (IOS) in schizophrenia, MIN has been proposed as a potential adjuvant treatment in this pathology. We tested an early therapeutic window, during adolescence, as prevention of the schizophrenia-related deficits in the maternal immune stimulation (MIS) animal model. Methods: On gestational day 15, Poly I:C or vehicle was injected in pregnant Wistar rats. A total 93 male offspring received MIN (30 mg/kg) or saline from postnatal day (PND) 35–49. At PND70, rats were submitted to the prepulse inhibition test. FDG-PET and T2-weighted MRI brain studies were performed at adulthood. IOS markers were evaluated in frozen brain tissue. Results: MIN treatment did not prevent prepulse inhibition test behavioral deficits in MIS offspring. However, MIN prevented morphometric abnormalities in the third ventricle but not in the hippocampus. Additionally, MIN reduced brain metabolism in cerebellum and increased it in nucleus accumbens. Finally, MIN reduced the expression of iNOS (prefrontal cortex, caudate-putamen) and increased the levels of KEAP1 (prefrontal cortex), HO1 and NQO1 (amygdala, hippocampus), and HO1 (caudate-putamen). Conclusions: MIN treatment during adolescence partially counteracts volumetric abnormalities and IOS deficits in the MIS model, likely via iNOS and Nrf2–ARE pathways, also increasing the expression of cytoprotective enzymes. However, MIN treatment during this peripubertal stage does not prevent sensorimotor gating deficits. Therefore, even though it does not prevent all the MIS-derived abnormalities evaluated, our results suggest the potential utility of early treatment with MIN in other schizophrenia domains.

20 April 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
DRDiego Romero-Miguel
Diego Romero-Miguel
MCMarta Casquero-Veiga
Marta Casquero-Veiga
JFJavier Fernández
Javier Fernández
Nicolás Lamanna RamaNicolás Lamanna Rama
Nicolás Lamanna Rama
VGVanessa Gómez-Rangel
Vanessa Gómez-Rangel
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro
The microbiota-gut-brain axis is a complex interconnected system altered in schizophrenia. The antioxidant N-acetylcysteine (NAC) has been proposed as an adjunctive therapy to antipsychotics in clinical trials, but its role in the microbiota-gut-brain axis has not been sufficiently explored. We aimed to describe the effect of NAC administration during pregnancy on the gut-brain axis in the offspring from the maternal immune stimulation (MIS) animal model of schizophrenia. Pregnant Wistar rats were treated with PolyI:C/Saline. Six groups of animals were studied according to the study factors: phenotype (Saline, MIS) and treatment (no NAC, NAC 7 days, NAC 21 days). Offspring were subjected to the novel object recognition test and were scanned using MRI. Caecum contents were used for metagenomics 16S rRNA sequencing. NAC treatment prevented hippocampal volume reduction and long-term memory deficits in MIS-offspring. In addition, MIS-animals showed lower bacterial richness, which was prevented by NAC. Moreover, NAC7/NAC21 treatments resulted in a reduction of proinflammatory taxons in MIS-animals and an increase in taxa known to produce anti-inflammatory metabolites. Early approaches, like this one, with anti-inflammatory/anti-oxidative compounds, especially in neurodevelopmental disorders with an inflammatory/oxidative basis, may be useful in modulating bacterial microbiota, hippocampal size, as well as hippocampal-based memory impairments.

3 August 2017 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
JGJúlia Gasull-Camós
Júlia Gasull-Camós
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro
MCMarta Casquero-Veiga
Marta Casquero-Veiga
DMDesco Menéndez Manuel
Desco Menéndez Manuel
FAFrancesc Artigas
Francesc Artigas
ACAnna Castañé
Anna Castañé
Glutamatergic neurotransmission has emerged as a novel target in antidepressant drug development, with a critical role of the ventral anterior cingulate cortex. We recently reported that blockade of the astrocytic glutamate transporter GLT-1 with dihydrokainic acid in infralimbic cortex (rodent equivalent of ventral anterior cingulate cortex), but not in the adjacent prelimbic cortex, evoked robust antidepressant-like effects through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation and increased serotonin release. 2-deoxy-2-[18F]-fluoro-D-glucose-positron emission tomography and computed tomography in 36 male Wistar rats microinfused bilaterally in prelimbic cortex or infralimbic cortex with dihydrokainic acid or vehicle. Dihydrokainic acid microinfusion in infralimbic cortex and prelimbic cortex evoked dramatically different regional patterns of subcortical activity. In infralimbic cortex, dihydrokainic acid selectively affected midbrain areas, whereas in prelimbic cortex it affected the basal ganglia, the thalamus, and both superior and inferior colliculi. These results highlight the differential connectivity of infralimbic and prelimbic cortex with subcortical brain regions and support the involvement of infralimbic cortex-midbrain pathway in the antidepressant-like effects of dihydrokainic acid.

6 January 2023 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
MCMarta Casquero-Veiga
Marta Casquero-Veiga
Nicolás Lamanna RamaNicolás Lamanna Rama
Nicolás Lamanna Rama
DRDiego Romero-Miguel
Diego Romero-Miguel
HRHenar Rojas-Marquez
Henar Rojas-Marquez
JAJulia Alcaide
Julia Alcaide
MMMª Luisa Soto Montenegro
Mª Luisa Soto Montenegro
Introduction: Prenatal infections are associated with an increased risk of the onset of schizophrenia. Rodent models of maternal immune stimulation (MIS) have been extensively used in preclinical studies. However, many of these studies only include males, omitting pathophysiological features unique to females. The aim of this study is to characterize the MIS model in female rats using positron emission tomography (PET), structural magnetic resonance imaging (MR), and neuroplasticiy studies.Methods: In gestational day 15, Poly I:C (or Saline) was injected into pregnant Wistar rats to induce the MIS model. Imaging studies: [18F]-fluoro-2-deoxy-D-glucose-PET scans of female-offspring were acquired at post-natal day (PND) 35 and PND100. Furthermore, T2-MR brain images were acquired in adulthood. Differences in FDG uptake and morphometry between groups were assessed with SPM12 and Regions of Interest (ROI) analyses. Ex vivo study: The density of parvalbumin expressing interneurons (PV), perineuronal nets (PNN), and parvalbumin expressing interneurons surrounded by perineuronal nets (PV-PNN) were evaluated in the prelimbic cortex and basolateral amygdala using confocal microscopy. ROIs and neuroplasticity data were analyzed by 2-sample T-test and 2-way-ANOVA analyses, respectively.Results: A significant increase in brain metabolism was found in all animals at adulthood compared to adolescence. MIS hardly modified brain glucose metabolism in females, highlighting a significant hypometabolism in the thalamus at adulthood. In addition, MIS induced gray matter (GM) enlargements in the pituitary, hippocampus, substantia nigra, and cingulate cortex, and GM shrinkages in some thalamic nuclei, cerebelar areas, and brainstem. Moreover, MIS induced white matter shrinkages in the cerebellum, brainstem and corpus callosum, along with cerebrospinal fluid enlargements in the lateral and 4th ventricles. Finally, MIS reduced the density of PV, PNN, and PV-PNN in the basolateral amygdala.Conclusion: Our work showed in vivo the differential pattern of functional and morphometric affectation in the MIS model in females, as well as the deficits caused at the synaptic level according to sex. The differences obtained highlight the relevance of including both sexes in psychiatric research in order to consider their pathophysiological particularities and successfully extend the benefits obtained to the entire patient population.